MarkWide Research

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 310-961-4489

24/7 Customer Support

All our reports can be tailored to meet our clients’ specific requirements, including segments, key players and major regions,etc.

Biopsy Market Analysis- Industry Size, Share, Research Report, Insights, Covid-19 Impact, Statistics, Trends, Growth and Forecast 2024-2032

Published Date: April, 2024
Base Year: 2023
Delivery Format: PDF+ Excel
Historical Year: 2017-2023
No of Pages: 263
Forecast Year: 2024-2032
SKU 528812c6021a Category

Corporate User License

$3,450.00

The biopsy market is an essential segment of the healthcare industry that plays a critical role in diagnosing and treating various diseases, including cancer. The market has been growing steadily over the past few years, driven by advances in technology and an increasing prevalence of cancer and other chronic diseases.

Biopsy is a medical procedure that involves the removal of a small tissue sample from a patient’s body for analysis. The sample is then examined under a microscope to detect any abnormal cells or tissues, which can be indicative of a disease or condition. Biopsies can be performed on various parts of the body, including the skin, breast, liver, lung, and prostate.

The biopsy market is a crucial segment of the healthcare industry that is involved in the diagnosis and treatment of various diseases. Biopsies are used to collect tissue samples for analysis and can be performed on various parts of the body. The market is driven by advances in technology and an increasing prevalence of cancer and other chronic diseases.

Executive Summary

The biopsy market is an essential segment of the healthcare industry that has been growing steadily over the past few years. The market is driven by advances in technology and an increasing prevalence of cancer and other chronic diseases. Biopsies are used to collect tissue samples for analysis and can be performed on various parts of the body. The market is expected to continue to grow in the coming years, driven by increasing demand for minimally invasive procedures and personalized medicine.

Biopsy Market

Key Market Insights

  1. The biopsy market is growing steadily, driven by advances in technology and an increasing prevalence of cancer and other chronic diseases.
  2. Biopsies can be performed on various parts of the body, including the skin, breast, liver, lung, and prostate.
  3. The market is expected to continue to grow in the coming years, driven by increasing demand for minimally invasive procedures and personalized medicine.

Market Drivers

  1. Increasing prevalence of cancer and other chronic diseases.
  2. Technological advancements in the biopsy procedures and devices.
  3. Rising demand for minimally invasive procedures.
  4. Growing awareness about the benefits of early detection and diagnosis of diseases.
  5. Rising healthcare expenditure in developing countries.

Market Restraints

  1. High cost of biopsy procedures and devices.
  2. Lack of skilled professionals in some regions.
  3. Potential risks associated with the biopsy procedures, such as bleeding and infection.
  4. Limited reimbursement policies for biopsy procedures in some regions.

Market Opportunities

  1. Increasing demand for personalized medicine.
  2. Rising adoption of liquid biopsy procedures.
  3. Growing focus on research and development of new biopsy techniques and devices.
  4. Emerging markets in Asia-Pacific and Latin America.

Market Dynamics

The biopsy market is a dynamic segment of the healthcare industry, driven by various factors such as increasing prevalence of cancer and other chronic diseases, advances in technology, and rising demand for minimally invasive procedures. The market is expected to continue to grow in the coming years, driven by increasing demand for personalized medicine and emerging markets in Asia-Pacific and Latin America.

Regional Analysis

The biopsy market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America is the largest market, followed by Europe and Asia-Pacific. The Asia-Pacific market is expected to grow at the highest CAGR during the forecast period, driven by rising healthcare expenditure, increasing prevalence of chronic diseases, and growing focus on research and development.

Competitive Landscape

The biopsy market is highly competitive, with several key players operating in the market. Some of the leading players in the market include Becton, Dickinson and Company, C. R. Bard, Inc., Danaher Corporation, Devicor Medical Products, Inc., Hologic, Inc., F. Hoffmann-La Roche Ltd, Koninklijke Philips N.V., Leica Biosystems Nussloch GmbH, and Thermo Fisher Scientific Inc. These companies are focusing on research and development of new biopsy techniques and devices, as well as strategic partnerships and acquisitions to expand their market presence.

Segmentation

The biopsy market is segmented based on product type, application, end-user, and region. Based on product type, the market is segmented into instruments, consumables, and services. Based on application, the market is segmented into breast biopsy, lung biopsy, liver biopsy, prostate biopsy, kidney biopsy, and others. Based on end-user, the market is segmented into hospitals, diagnostic centers, and research centers.

Category-wise Insights

  1. Instruments segment is the largest segment in the biopsy market, driven by technological advancements and rising demand for minimally invasive procedures.
  2. Breast biopsy is the largest application segment, followed by lung biopsy and liver biopsy.
  3. Hospitals are the largest end-user segment, followed by diagnostic centers and research centers.

Key Benefits for Industry Participants and Stakeholders

  1. Comprehensive analysis of the biopsy market, including market trends, drivers, restraints, opportunities, and dynamics.
  2. Detailed analysis of the market segmentation and competitive landscape.
  3. Insights into the key trends and developments in the market.
  4. Information about the impact of Covid-19 on the biopsy market.
  5. Strategic recommendations for industry participants and stakeholders.

SWOT Analysis

  1. Strengths: Technological advancements in biopsy procedures and devices, rising demand for minimally invasive procedures, and increasing prevalence of chronic diseases.
  2. Weaknesses: High cost of biopsy procedures and devices, potential risks associated with the procedures, and limited reimbursement policies in some regions.
  3. Opportunities: Increasing demand for personalized medicine, rising adoption of liquid biopsy procedures, and growing focus on research and development.
  4. Threats: Competition from new entrants, changing regulatory environment, and economic uncertainty.

Market Key Trends

  1. Rising demand for minimally invasive procedures.
  2. Increasing adoption of liquid biopsy procedures.
  3. Growing focus on research and development of new biopsy techniques and devices.
  4. Increasing demand for personalized medicine.

Covid-19 Impact

The Covid-19 pandemic has had a significant impact on the biopsy market, with disruptions in the supply chain, reduced demand for non-essential procedures, and delays in research and development activities. However, the market is expected to recover in the coming years, driven by increasing demand for personalized medicine and emerging markets in Asia-Pacific and Latin America.

Key Industry Developments

  1. In April 2021, Becton, Dickinson and Company announced the launch of a new needle for breast biopsy procedures, designed to improve accuracy and reduce the need for additional procedures.
  2. In January 2021, Danaher Corporation completed the acquisition of Aldevron, a provider of biologics services for the biotech industry.
  3. In November 2020, Thermo Fisher Scientific Inc. announced the launch of a new liquid biopsy assay for lung cancer detection, designed to provide faster and more accurate results.

Analyst Suggestions

  1. Focus on research and development of new biopsy techniques and devices, particularly in emerging markets.
  2. Expand market presence through strategic partnerships and acquisitions.
  3. Address the high cost of biopsy procedures and devices through innovative pricing strategies.
  4. Invest in training and development of skilled professionals to meet the growing demand for biopsy procedures.

Future Outlook

The biopsy market is expected to continue to grow in the coming years, driven by advances in technology, increasing demand for personalized medicine, and emerging markets in Asia-Pacific and Latin America. The market is expected to face challenges such as high cost of procedures and devices, potential risks associated with the procedures, and limited reimbursement policies in some regions. However, the market is expected to overcome these challenges through innovative pricing strategies, advancements in technology, and increased awareness about the benefits of early detection and diagnosis of diseases.

Conclusion

The biopsy market is a crucial segment of the healthcare industry that plays a critical role in diagnosing and treating various diseases, including cancer. The market has been growing steadily over the past few years, driven by advances in technology and an increasing prevalence of cancer and other chronic diseases. The market is expected to continue to grow in the coming years, driven by increasing demand for minimally invasive procedures and personalized medicine. Industry participants and stakeholders can benefit from a comprehensive analysis of the market, including market trends, drivers, restraints, opportunities, and dynamics, as well as strategic recommendations for future growth.

Biopsy Market:

Segmentation Details
Product Needle-based Biopsy Instruments, Biopsy Forceps, Biopsy Guidance Systems, Others
Procedure Needle Aspiration Biopsy, Core Needle Biopsy, Vacuum-assisted Biopsy, Others
Application Breast Biopsy, Prostate Biopsy, Lung Biopsy, Liver Biopsy, Others
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Leading Companies in the Biopsy Market:

  1. Becton, Dickinson and Company
  2. Medtronic plc
  3. Danaher Corporation
  4. Hologic, Inc.
  5. Devicor Medical Products, Inc. (Leica Biosystems)
  6. Olympus Corporation
  7. Boston Scientific Corporation
  8. Intact Medical Corporation
  9. FUJIFILM Holdings Corporation
  10. Cook Medical

North America
o US
o Canada
o Mexico

Europe
o Germany
o Italy
o France
o UK
o Spain
o Denmark
o Sweden
o Austria
o Belgium
o Finland
o Turkey
o Poland
o Russia
o Greece
o Switzerland
o Netherlands
o Norway
o Portugal
o Rest of Europe

Asia Pacific
o China
o Japan
o India
o South Korea
o Indonesia
o Malaysia
o Kazakhstan
o Taiwan
o Vietnam
o Thailand
o Philippines
o Singapore
o Australia
o New Zealand
o Rest of Asia Pacific

South America
o Brazil
o Argentina
o Colombia
o Chile
o Peru
o Rest of South America

The Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Israel
o Kuwait
o Oman
o North Africa
o West Africa
o Rest of MEA

Important Questions Covered in this Study

Why Choose MWR ?

Quality Research

Our goal is to provide high-quality data that stimulates growth and creates a win-win situations.

Unlimited User Access

We offer Corporate User license access on all our reports in which you can share the report with your entire team without any restrictions.

Free Company Inclusion

We give you an option to include 3-4 additional company players of your choice in our report without any extra charges.

Post Sale Assistance

Unlimited post sales service with an account manager dedicated to making sure that all your needs are met.

Covid-19 Impact Analysis

All our research report includes latest Covid-19 Impact and its analysis.

Client Associated with us

GET A FREE SAMPLE REPORT

This free sample study provides a complete overview of the report, including executive summary, market segments, competitive analysis, country level analysis and more.

Client Testimonials

GET A FREE SAMPLE REPORT

This free sample study provides a complete overview of the report, including executive summary, market segments, competitive analysis, country level analysis and more.

error: Content is protected !!
Scroll to Top

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 360 2221

24/7 Customer Support

Download Free Sample PDF
This website is safe and your personal information will be secured. Privacy Policy
Request for Discount
This website is safe and your personal information will be secured. Privacy Policy
Speak to Analyst
This website is safe and your personal information will be secured. Privacy Policy

Download Free Sample PDF